Evotec SE (EVO) Divestments (2025 - 2026)
Evotec SE (EVO) reported Divestments of -$4512.1 for Q1 2026, down 100.0% sequentially from $258.8 million in Q4 2025.
Evotec SE (EVO) Divestments (2025 - 2026) Analysis & Trends
Evotec SE (EVO) has 2 years of Divestments data on file, last reported at -$4512.1 in Q1 2026.
- For the quarter ending Q1 2026, Divestments changed N/A year-over-year to -$4512.1; the trailing twelve-month figure through Mar 2026 stood at $258.8 million (changed N/A YoY), and the FY2025 full-year result was $258.8 million, up 2205.47% from the prior year.
- Divestments declined to -$4512.1 in Q1 2026, from $258.8 million in the prior quarter.
- In the past five years, Divestments ranged from a high of $258.8 million in Q4 2025 to a low of -$4512.1 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 42.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.28 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | -4,512.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,512.05 |
| Dec 31, 2025 | 258.81 Mn |